Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.77 USD
Change Today +0.33 / 5.12%
Volume 1.2M
ARAY On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

accuray inc (ARAY) Snapshot

Open
$6.43
Previous Close
$6.44
Day High
$6.85
Day Low
$6.38
52 Week High
04/13/15 - $10.01
52 Week Low
08/20/15 - $5.65
Market Cap
539.9M
Average Volume 10 Days
2.0M
EPS TTM
$-0.52
Shares Outstanding
79.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ACCURAY INC (ARAY)

accuray inc (ARAY) Related Businessweek News

No Related Businessweek News Found

accuray inc (ARAY) Details

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The company’s CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables delivery of precise, high dose radiation while patients breathe normally. It also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. The company markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors and sales agents in Europe, Japan and other countries of Asia, South America, and internationally to hospitals and stand-alone treatment facilities. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.

accuray inc (ARAY) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $637.5K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $293.0K
Chief Commercial Officer and Executive Vice P...
Total Annual Compensation: $368.1K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $330.6K
Compensation as of Fiscal Year 2014.

accuray inc (ARAY) Key Developments

Accuray Incorporated Receives Multi-System Order from 21st Century Oncology

Accuray Incorporated announced it has received a multi-system order from 21st Century Oncology for one CyberKnife® M6™ and four TomoHDA™ Systems. These are the latest generation CyberKnife and TomoTherapy Systems, and are used worldwide to provide extremely precise radiation treatments for cancerous and non-cancerous tumors throughout the body. The TomoTherapy Systems will replace conventional linear accelerators in single vault freestanding centers, reinforcing the TomoTherapy's value as a mainstream radiation therapy device. Accuray booked the order in its first fiscal quarter of 2016.

Accuray Incorporated Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2015; Provides Earnings Guidance for the Fiscal Year 2016

Accuray Incorporated announced unaudited consolidated earnings results for the fourth quarter and full year ended June 30, 2015. For the quarter, the company reported total net revenue of $101.750 million against $102.000 million a year ago. Loss from operations was $1.478 million against $4.667 million a year ago. Loss before provision for income taxes was $5.492 million against $9.336 million a year ago. Net loss was $5.600 million against $9.809 million a year ago. Net loss per share-basic and diluted was $0.07 against $0.13 a year ago. Adjusted EBITDA was $6.659 million against $2.498 million a year ago. For the six months, the company reported total net revenue of $379.801 million against $369.419 million a year ago. Loss from operations was $19.169 million against $18.144 million a year ago. Loss before provision for income taxes was $37.4790 million against $32.360 million a year ago. Net loss was $40.209 million against $35.448 million a year ago. Net loss per share-basic and diluted was $0.51 against $0.47 a year ago. Adjusted EBITDA was $11.791 million against $13.276 million a year ago. For the fiscal year 2016, the company’s revenue expected to be in the range of $395 million to $410 million. This represents growth of 4% to 8% over revenue in fiscal 2015. Revenue by quarter as a percentage of total year is expected to be similar to fiscal 2015. The company expects fiscal 2016 adjusted EBITDA to be in the range of $25 million to $35 million. This represents growth of 112% to 197% over adjusted EBITDA in fiscal 2015, reflecting flat to moderately improving gross margins and ongoing expense control. In order to achieve adjusted EBITDA range, the company expects gross margins to be flat at the low end and 200 basis points improved at the high end. GAAP net loss expected to be in the range of $29.200 million to $19.300 million. Amortization of intangibles expected to be $7.950 million. Depreciation expected to be $10.850 million. Interest expense, net expected to be $17.300.

Accuray Incorporated to Report Q4, 2015 Results on Aug 20, 2015

Accuray Incorporated announced that they will report Q4, 2015 results at 5:00 PM, Eastern Standard Time on Aug 20, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARAY:US $6.77 USD +0.33

ARAY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elekta AB kr53.20 SEK -0.55
Mitsubishi Heavy Industries Ltd ¥598.20 JPY +22.80
RaySearch Laboratories AB kr117.25 SEK -2.00
Varian Medical Systems Inc $82.47 USD +0.65
ViewRay Inc $6.85 USD +0.05
View Industry Companies
 

Industry Analysis

ARAY

Industry Average

Valuation ARAY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book 7.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACCURAY INC, please visit www.accuray.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.